endometrial cancer

Showing NaN - NaN of 42

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, Endometrial Cancer Trial in Oklahoma City, Houston (AO-252)

Recruiting
  • Triple Negative Breast Cancer
  • +2 more
  • Oklahoma City, Oklahoma
  • +1 more
Nov 13, 2023

Endometrial Cancer, Endometrioid Tumor, Cancer Trial in Oklahoma City (nab-sirolimus)

Not yet recruiting
  • Endometrial Cancer
  • +5 more
  • Oklahoma City, Oklahoma
    University Oklahoma Stephenson Cancer Center
Aug 16, 2023

Endometrial Cancer, Esophageal Cancer, Esophagogastric Junction (EGJ) Trial in Worldwide (Autologous genetically modified

Recruiting
  • Endometrial Cancer
  • +8 more
  • Autologous genetically modified ADP-A2M4CD8 cells alone or in combination with nivolumab every four weeks or pembrolizumab every 6 weeks
  • Orlando, Florida
  • +21 more
Feb 2, 2023

Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer Trial in United States (PRO1184)

Recruiting
  • Ovarian Cancer
  • +8 more
  • Scottsdale, Arizona
  • +11 more
Jan 31, 2023

Endometrial Cancer Trial in Oklahoma City (Pembrolizumab, Vaginal cuff brachytherapy (VCB), Paclitaxel)

Recruiting
  • Endometrial Cancer
  • Oklahoma City, Oklahoma
    Stephenson Cancer Center
Jan 9, 2023

Solid Tumor, Colorectal Cancer, Non Small Cell Lung Cancer Trial in United States (TPST-1495 twice daily, TPST-1495 once daily

Recruiting
  • Solid Tumor
  • +8 more
  • TPST-1495 twice daily
  • +2 more
  • Baltimore, Maryland
  • +8 more
Jan 4, 2023

Advanced Solid Malignancy, Safety and Tolerability, Pharmacokinetics Trial in Worldwide (AZD5363)

Active, not recruiting
  • Advanced Solid Malignancy
  • +13 more
  • Los Angeles, California
  • +33 more
Dec 22, 2022

Endometrial Cancer Trial in Birmingham, Saint Louis, Oklahoma City (Bevacizumab, Atezolizumab)

Active, not recruiting
  • Endometrial Cancer
  • Birmingham, Alabama
  • +2 more
Nov 21, 2022

Endometrial Cancer Trial in Worldwide (Selinexor, Matching for selinexor)

Active, not recruiting
  • Endometrial Cancer
  • Tucson, Arizona
  • +104 more
Aug 11, 2022

NSCLC, Renal Cell Cancer, Colorectal Cancer Trial in Australia, United States (CPI-006, CPI-006 + ciforadenant, CPI-006 +

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • +12 more
  • Tucson, Arizona
  • +26 more
Aug 1, 2022

Ovarian Cancer, Breast Cancer, Pancreatic Cancer Trial in Worldwide (AZD5305, Paclitaxel, Carboplatin)

Recruiting
  • Ovarian Cancer
  • +12 more
  • San Francisco, California
  • +44 more
Jul 12, 2022

Ovarian Cancer, Endometrial Cancer, Cervix Cancer Trial in Oklahoma City (SHetA2)

Recruiting
  • Ovarian Cancer
  • +2 more
  • Oklahoma City, Oklahoma
    Stephenson Cancer Center
Jul 7, 2022

Obesity, Endometrial Cancer, Bariatric Surgery Candidate Trial in Oklahoma City (Standard Education, Educational Video)

Not yet recruiting
  • Obesity
  • +2 more
  • Standard Education
  • Educational Video
  • Oklahoma City, Oklahoma
    Stephenson Cancer Center
May 25, 2022

Breast Cancer, Ovarian Cancer, Endometrial Cancer Trial in Korea, Republic of, United States (FPA150, Pembrolizumab)

Completed
  • Breast Cancer
  • +3 more
  • FPA150
  • Pembrolizumab
  • Scottsdale, Arizona
  • +17 more
Jan 6, 2022

Uterine Cervical Cancer, Endometrial Cancer Trial in United States (Zalypsis ( PM00104))

Terminated
  • Uterine Cervical Cancer
  • Endometrial Cancer
  • Zalypsis ( PM00104)
  • Boston, Massachusetts
  • +3 more
Sep 30, 2021

Endometrial Cancer, Papillary Serous, Clear Cell Endometrial Cancer Trial in Oklahoma City (Vaginal Cuff Brachytherapy,

Active, not recruiting
  • Endometrial Cancer
  • +2 more
  • Vaginal Cuff Brachytherapy
  • +2 more
  • Oklahoma City, Oklahoma
    Stephenson Cancer Center
Aug 13, 2021

Endometrial Cancer Trial in Norway, United States (drug, procedure, radiation)

Completed
  • Endometrial Cancer
  • Los Angeles, California
  • +28 more
Oct 21, 2020

Solid Tumors, Ovarian Cancer, Endometrial Cancer Trial in United States (ARQ 092 + carboplatin + paclitaxel (Closed), ARQ 092 +

Terminated
  • Solid Tumors
  • +2 more
  • ARQ 092 + carboplatin + paclitaxel (Closed)
  • +2 more
  • Grand Rapids, Michigan
  • +4 more
Sep 28, 2020

Endometrial Cancer, Papillary Serous, Clear Cell Endometrial Cancer Trial in Oklahoma City (Vaginal Cuff Brachytherapy)

Completed
  • Endometrial Cancer
  • +2 more
  • Vaginal Cuff Brachytherapy
  • Oklahoma City, Oklahoma
    University of Oklahoma Health Sciences Center
Aug 7, 2020

Endometrial Cancer, Endometrial Adenocarcinoma, Endometrial Serous Adenocarcinoma Trial in Oklahoma City (Mirvetuximab

Withdrawn
  • Endometrial Cancer
  • +3 more
  • Oklahoma City, Oklahoma
    Stephenson Cancer Center
Jun 25, 2019

Endometrial Cancer Trial in Worldwide (AEZS-108 / zoptarelin doxorubicin, doxorubicin)

Completed
  • Endometrial Cancer
  • Phoenix, Arizona
  • +122 more
Jul 5, 2018

Endometrial Cancer Trial in Worldwide (Ixabepilone, Doxorubicin, Paclitaxel)

Terminated
  • Endometrial Cancer
  • Mobile, Alabama
  • +92 more
Jan 27, 2017

Endometrial Cancer, Endometrial Tumors Trial in Belgium, United States (XL147 (SAR245408))

Completed
  • Endometrial Cancer
  • Endometrial Neoplasms
  • XL147 (SAR245408)
  • Newport Beach, California
  • +12 more
May 9, 2016

Endometrial Cancer, Psychosocial Effects of Cancer and Its Treatment Trial in United States (cisplatin, doxorubicin HCl, low-LET

Completed
  • Endometrial Cancer
  • Psychosocial Effects of Cancer and Its Treatment
  • Birmingham, Alabama
  • +57 more
Feb 12, 2014